growth - Stock trades at 35-45x P/E and 5.9x P/B, pricing in 15-18% revenue CAGR and margin expansion as new hospitals mature.
Moderate sensitivity through two channels: (1) Valuation multiple compression - stock trades at 35-45x forward P/E…
Watch on earnings: India GDP growth rate (proxy for discretionary healthcare spending and corporate insurance enrollment), Insurance claim settlement ratios and TPA payment cycles (impacts receivables and cash conversion), Medical tourism arrivals to India from Middle East/Africa (drives high-margin international patient revenue).
One Sentence Summary:
Indraprastha Medical: the story is balanced — bed occupancy rates and arpob trends across mature vs.
Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.